Cargando…

Imaging markers of disability in aquaporin-4 immunoglobulin G seropositive neuromyelitis optica: a graph theory study

Neuromyelitis optica spectrum disorders lack imaging biomarkers associated with disease course and supporting prognosis. This complex and heterogeneous set of disorders affects many regions of the central nervous system, including the spinal cord and visual pathway. Here, we use graph theory-based m...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chien, Claudia, Oertel, Frederike Cosima, Siebert, Nadja, Zimmermann, Hanna, Asseyer, Susanna, Kuchling, Joseph, Scheel, Michael, Ruprecht, Klemens, Bellmann-Strobl, Judith, Paul, Friedemann, Brandt, Alexander U
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2019
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7425339/ https://www.ncbi.nlm.nih.gov/pubmed/32954267 http://dx.doi.org/10.1093/braincomms/fcz026

Ejemplares similares

Differences in Advanced Magnetic Resonance Imaging in MOG-IgG and AQP4-IgG Seropositive Neuromyelitis Optica Spectrum Disorders: A Comparative Study
por: Schmidt, Felix A., et al.
Publicado: (2020)

Optic chiasm measurements may be useful markers of anterior optic pathway degeneration in neuromyelitis optica spectrum disorders
por: Juenger, Valentin, et al.
Publicado: (2020)

Serum GFAP and NfL as disease severity and prognostic biomarkers in patients with aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder
por: Schindler, Patrick, et al.
Publicado: (2021)

Lateral geniculate nucleus volume changes after optic neuritis in neuromyelitis optica: A longitudinal study
por: Papadopoulou, Athina, et al.
Publicado: (2021)

Impaired motion perception is associated with functional and structural visual pathway damage in multiple sclerosis and neuromyelitis optica spectrum disorders
por: Ayadi, Noah, et al.
Publicado: (2021)

Pain in AQP4-IgG-positive and MOG-IgG-positive neuromyelitis optica spectrum disorders
por: Asseyer, Susanna, et al.
Publicado: (2018)

Altered fovea in AQP4-IgG–seropositive neuromyelitis optica spectrum disorders
por: Motamedi, Seyedamirhosein, et al.
Publicado: (2020)

AQP4-IgG autoimmunity in Japan and Germany: Differences in clinical profiles and prognosis in seropositive neuromyelitis optica spectrum disorders
por: Asseyer, Susanna, et al.
Publicado: (2021)

Structure–function correlates of vision loss in neuromyelitis optica spectrum disorders
por: Gigengack, Norman K., et al.
Publicado: (2022)

Anti-aquaporin 4 IgG Is Not Associated With Any Clinical Disease Characteristics in Neuromyelitis Optica Spectrum Disorder
por: Schmetzer, Oliver, et al.
Publicado: (2021)

Microstructural visual system changes in AQP4-antibody–seropositive NMOSD
por: Oertel, Frederike C., et al.
Publicado: (2017)

Quantitative 7T MRI does not detect occult brain damage in neuromyelitis optica
por: Pasquier, Baptiste, et al.
Publicado: (2019)

Low-Density Granulocytes Are a Novel Immunopathological Feature in Both Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder
por: Ostendorf, Lennard, et al.
Publicado: (2019)

Cognitive Impairment in Neuromyelitis Optica Spectrum Disorders: A Review of Clinical and Neuroradiological Features
por: Oertel, Frederike Cosima, et al.
Publicado: (2019)

Comparison of probabilistic tractography and tract-based spatial statistics for assessing optic radiation damage in patients with autoimmune inflammatory disorders of the central nervous system
por: Kuchling, Joseph, et al.
Publicado: (2018)

Diagnostic value of intereye difference metrics for optic neuritis in aquaporin-4 antibody seropositive neuromyelitis optica spectrum disorders
por: Oertel, Frederike Cosima, et al.
Publicado: (2023)

Fatal anti-aquaporin-4 seropositive neuromyelitis optica spectrum disorder in tuberculosis
por: Sridhar, Siddharth, et al.
Publicado: (2014)

Olfactory Dysfunction in Patients with Neuromyelitis Optica
por: Schmidt, Felix, et al.
Publicado: (2013)

Cerebrospinal fluid antibodies to aquaporin-4 in neuromyelitis optica and related disorders: frequency, origin, and diagnostic relevance
por: Jarius, Sven, et al.
Publicado: (2010)

Antibody to Aquaporin 4 in the Diagnosis of Neuromyelitis Optica
por: Paul, Friedemann, et al.
Publicado: (2007)

Longitudinal analysis of T1w/T2w ratio in patients with multiple sclerosis from first clinical presentation
por: Cooper, Graham, et al.
Publicado: (2021)

Neuromyelitis optica pathogenesis and aquaporin 4
por: Graber, David J, et al.
Publicado: (2008)

The Detection of Retina Microvascular Density in Subclinical Aquaporin-4 Antibody Seropositive Neuromyelitis Optica Spectrum Disorders
por: Chen, Yihong, et al.
Publicado: (2020)

Evaluation of the ‘ring sign’ and the ‘core sign’ as a magnetic resonance imaging marker of disease activity and progression in clinically isolated syndrome and early multiple sclerosis
por: Blindenbacher, Nelly, et al.
Publicado: (2020)

Visualizing the Central Nervous System: Imaging Tools for Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorders
por: Kuchling, Joseph, et al.
Publicado: (2020)

Optical coherence tomography in myelin-oligodendrocyte-glycoprotein antibody-seropositive patients: a longitudinal study
por: Oertel, Frederike C., et al.
Publicado: (2019)

Antibodies to aquaporin-1 are not present in neuromyelitis optica
por: Schanda, Kathrin, et al.
Publicado: (2015)

Optical coherence tomography in neuromyelitis optica spectrum disorders: potential advantages for individualized monitoring of progression and therapy
por: Oertel, Frederike C., et al.
Publicado: (2017)

Corrigendum: The Detection of Retina Microvascular Density in Subclinical Aquaporin-4 Antibody Seropositive Neuromyelitis Optica Spectrum Disorders
por: Chen, Yihong, et al.
Publicado: (2020)

Standardization of T1w/T2w Ratio Improves Detection of Tissue Damage in Multiple Sclerosis
por: Cooper, Graham, et al.
Publicado: (2019)

Uncovering convolutional neural network decisions for diagnosing multiple sclerosis on conventional MRI using layer-wise relevance propagation
por: Eitel, Fabian, et al.
Publicado: (2019)

Insufficient treatment of severe depression in neuromyelitis optica spectrum disorder
por: Chavarro, Velina S., et al.
Publicado: (2016)

Update on the diagnosis and treatment of neuromyelitis optica: Recommendations of the Neuromyelitis Optica Study Group (NEMOS)
por: Trebst, Corinna, et al.
Publicado: (2013)

The neuromyelitis optica presentation and the aquaporin-4 antibody in HIV-seropositive and seronegative patients in KwaZulu-Natal, South Africa
por: Bhigjee, Ahmed I., et al.
Publicado: (2017)

Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: A multicentre study of 175 patients
por: Jarius, Sven, et al.
Publicado: (2012)

Ovarian Reserve in Women With Neuromyelitis Optica Spectrum Disorder
por: Thöne, Jan, et al.
Publicado: (2018)

Investigating paraneoplastic aquaporin‐4‐IgG‐seropositive neuromyelitis optica spectrum disorder through a data‐driven approach
por: Dinoto, Alessandro, et al.
Publicado: (2022)

Antibody to aquaporin-4 in the long-term course of neuromyelitis optica
por: Jarius, S., et al.
Publicado: (2008)

Patterns of Antibody Binding to Aquaporin-4 Isoforms in Neuromyelitis Optica
por: Mader, Simone, et al.
Publicado: (2010)

Update on the diagnosis and treatment of neuromyelits optica spectrum disorders (NMOSD) – revised recommendations of the Neuromyelitis Optica Study Group (NEMOS). Part I: Diagnosis and differential diagnosis
por: Jarius, Sven, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_cmajm4vc8fuvero8ep62bg2vl6